Imfinzi (durvalumab) - AstraZeneca
PVX-410 - OncoPep
Hiltonol (poly-ICLC) - Oncovir
http://clinicaltrials.gov/ct2/show/NCT02826434
 
Jan 1, 2024
 
Prev Next